None listed
Conditions
Interventions
None listed
Sponsors
Ildong pharmaceutical
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients with hypertension (=140/90mmHg or antihypertensive medication) aged 19 years and over who agreed to patient informed consent
Exclusion criteria
Exclusion criteria: Women who are pregnant or nursing mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| proportion of participants eligible for statin therapy and treatment rate in patients with hypertension in primary care clinic | — |
Secondary
| Measure | Time frame |
|---|---|
| comparison between primary care clinic and tertiary medical center in proportion of participants eligible for statin management ;comparison between primary care clinic and tertiary medical center in treatment and control rate of participants eligible for statin therapy;comparison between primary care clinic and tertiary medical center in median LDL-C, Total cholesterol, Triglyceride, HDL-C, non-HDL-C of participants eligible for statin therapy ;comparison between primary care clinic and tertiary medical center in proportion of participants eligible for antiplatelet therapy ;comparison between primary care clinic and tertiary medical center in treatment rate of participants eligible for antiplatelet therapy | — |
Countries
Korea, Republic of
Contacts
Public ContactTAE-KYEONG LEE
Seoul National University Hospital
Outcome results
None listed